metformin has been researched along with Biliary Tract Cancer in 3 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The impact of statins, aspirin and metformin use on recurrence-free (RFS) and overall survival (OS) of patients with biliary tract cancer (BTC) has not been evaluated." | 7.81 | Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer. ( Aneja, P; Horgan, AM; Knox, JJ; Le, LW; McKeever, E; McNamara, MG, 2015) |
| "The impact of statins, aspirin and metformin use on recurrence-free (RFS) and overall survival (OS) of patients with biliary tract cancer (BTC) has not been evaluated." | 3.81 | Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer. ( Aneja, P; Horgan, AM; Knox, JJ; Le, LW; McKeever, E; McNamara, MG, 2015) |
| "Metformin was not associated with BTC risk (HR, 0." | 1.72 | Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study. ( Borad, MJ; Brusselaers, N; Harmsen, WS; Marcano-Bonilla, L; Patel, T; Petersen, GM; Roberts, LR; Sadr-Azodi, O; Schleck, CD; Therneau, TM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Marcano-Bonilla, L | 1 |
| Schleck, CD | 1 |
| Harmsen, WS | 1 |
| Sadr-Azodi, O | 1 |
| Borad, MJ | 1 |
| Patel, T | 1 |
| Petersen, GM | 1 |
| Therneau, TM | 1 |
| Roberts, LR | 1 |
| Brusselaers, N | 1 |
| Chen, J | 1 |
| Jin, H | 1 |
| Zhou, H | 1 |
| Liu, K | 1 |
| McNamara, MG | 1 |
| Aneja, P | 1 |
| Le, LW | 1 |
| Horgan, AM | 1 |
| McKeever, E | 1 |
| Knox, JJ | 1 |
1 review available for metformin and Biliary Tract Cancer
| Article | Year |
|---|---|
Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis.
Topics: Biliary Tract Neoplasms; Diabetes Mellitus; Humans; Hypoglycemic Agents; Metformin; Prognosis | 2023 |
2 other studies available for metformin and Biliary Tract Cancer
| Article | Year |
|---|---|
Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bile Duct Neoplasms; Bile Ducts, Intra | 2022 |
Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
Topics: Aged; Aspirin; Biliary Tract Neoplasms; Cardiovascular Agents; Comorbidity; Disease Progression; Dis | 2015 |